Suchergebnisse - "Bosker, Gideon"

PubPharm (20)

1

Network-based identification and pharmacological targeting of host cell master regulators induced by SARS-CoV-2 infection

enthalten in: bioRxiv.org | 2024

von Laise, P. | Stanifer, M. | Bosker, G. | +13

2

A Patient-to-Model-to-Patient (PMP) Cancer Drug Discovery Protocol for Identifying and Validating Therapeutic Agents Targeting Tumor Regulatory Architecture

enthalten in: Current protocols | 2022

von Laise, P. | Bosker, G. | Califano, A. | +1

3

A Model for Network-Based Identification and Pharmacological Targeting of Aberrant, Replication-Permissive Transcriptional Programs Induced by Viral Infection

enthalten in: ResearchSquare.com | 2022

von Laise, P. | Stanifer, M. | Bosker, G. | +13

4

A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection

enthalten in: Communications biology | 2022

von Laise, P. | Stanifer, M. | Bosker, G. | +13

UpdateOf: Res Sq. 2022 Feb 04;:. - PMID 35132404

5

A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection

enthalten in: Communications biology | 19 July 2022

von Laise, P. | Stanifer, M. | Bosker, G. | +13

6

A Model for Network-Based Identification and Pharmacological Targeting of Aberrant, Replication-Permissive Transcriptional Programs Induced by Viral Infection

enthalten in: Research square | 2022

von Laise, P. | Stanifer, M. | Bosker, G. | +13

UpdateIn: Commun Biol. 2022 Jul 19;5(1):714. - PMID 35854100

7

A Patient‐to‐Model‐to‐Patient (PMP) Cancer Drug Discovery Protocol for Identifying and Validating Therapeutic Agents Targeting Tumor Regulatory Architecture

enthalten in: Current Protocols | 2022

von Laise, P. | Bosker, G. | Califano, A. | +1

8

Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma : report of a phase 2 trial and exploratory biomarker analyses

enthalten in: British journal of haematology | 2021

von Landsburg, D. | Barta, S. | Ramchandren, R. | +16

9

Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma : report of a phase 2 trial and exploratory biomarker analyses

enthalten in: British Journal of Haematology | 2021

von Landsburg, D. | Barta, S. | Ramchandren, R. | +16

10

The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States

enthalten in: bioRxiv.org | 2020

von Laise, P. | Bosker, G. | Sun, X. | +7